World Journal of Transplantation - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Chukwu CA, Kalra PA, Lowe M, Poulton K, Augustine T, Rao A. Outcomes of basiliximab vs alemtuzumab induction in kidney allograft recipients with matched immunological Profiles: A retrospective cohort study. World J Transplant 2026; 16(1): 111959 [PMID: 41607816 DOI: 10.5500/wjt.v16.i1.111959]
URL:	https://www.wjgnet.com/2220-3230/full/v16/i1/111959.htm

(26) (47) (0) (0) (0) (1) (497) (1)

Number	Citing Articles
1	Luca Galassi, Erica Altamura, Lina Azzahrani, Federica Facchinetti, Matteo Lino Ravini. Letter to the Editor: Induction therapy as a long-term commitment: Lessons from comparative outcomes of alemtuzumab and basiliximab. World Journal of Transplantation 2026; 16(2): 118962 doi: 10.5500/wjt.v16.i2.118962 Abstract(4) \| Core Tip(2) \| Full Article(HTML)(11) \| Full Article (PDF)-400K(1) \| Full Article with Cover (PDF)-797K(1) \| Full Article (XML)-69K(2) \| Audio-729K(2) \| Peer-Review Report-211K(1) \| Answering Reviewers-106K(2) \| Times Cited (0) \| Total Visits (18) \| Open

Number

Citing Articles

Luca Galassi, Erica Altamura, Lina Azzahrani, Federica Facchinetti, Matteo Lino Ravini. Letter to the Editor: Induction therapy as a long-term commitment: Lessons from comparative outcomes of alemtuzumab and basiliximab. World Journal of Transplantation 2026; 16(2): 118962 doi: 10.5500/wjt.v16.i2.118962

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.